GC
EXAS

Globeflex Capital’s Exact Sciences EXAS Stock Holding History

Globeflex Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,764
Closed -$1.02M – 489
2024
Q1 		$1.02M Hold
14,764
– – 0.1% 180
2023
Q4 		$1.09M Hold
14,764
– – 0.11% 175
2023
Q3 		$1.01M Buy
14,764
+1,064
+8% +$90.3K 0.12% 171
2023
Q2 		$1.29M Hold
13,700
– – 0.14% 153
2023
Q1 		$929K Hold
13,700
– – 0.11% 193
2022
Q4 		$678K Buy
+13,700
New +$560K 0.09% 224

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Globeflex Capital's EXAS Position: Q2 2024 in Review

Globeflex Capital sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 14,764 shares — an estimated $1.02M sold.

Globeflex Capital first reported a position in EXAS in Q4 2022 and held it in 6 quarters. The position peaked at $1.29M in Q2 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Globeflex Capital reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Globeflex Capital sold 14,764 Exact Sciences shares in Q2 2024, an estimated $1.02M.
  • Globeflex Capital first reported a position in Exact Sciences in Q4 2022 and held it in 6 quarters.
  • Globeflex Capital's Exact Sciences position peaked at $1.29M in Q2 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Globeflex Capital's 13F filing for Q2 2024, filed 13 Aug 2024.